German Cancer Society

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1016/s1470-2045(17)30904-x Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
https://doi.org/10.1016/s0140-6736(16)32454-0 Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
https://doi.org/10.1038/nrc.2016.18 Radiation oncology in the era of precision medicine
https://doi.org/10.1038/nature14980 Telomerase activation by genomic rearrangements in high-risk neuroblastoma
https://doi.org/10.1001/jamaoncol.2015.0830 Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab
https://doi.org/10.1136/bmj.c4737 Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials
https://doi.org/10.1038/s41467-020-20603-4 Sarcoma classification by DNA methylation profiling
https://doi.org/10.1200/jco.19.00308 Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
https://doi.org/10.1016/j.annonc.2022.04.007 The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline
https://doi.org/10.1002/eji.202170126 Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
https://doi.org/10.1038/s41586-020-2698-6 Pervasive chromosomal instability and karyotype order in tumour evolution
https://doi.org/10.1016/j.semcancer.2017.02.011 Cancer stem cells: The root of tumor recurrence and metastases
https://doi.org/10.1016/s0140-6736(23)01054-1 Primary brain tumours in adults
https://doi.org/10.1016/j.semcancer.2014.07.009 Focal adhesion signaling and therapy resistance in cancer
https://doi.org/10.1016/j.radonc.2016.01.004 First clinical application of a prompt gamma based in vivo proton range verification system
https://doi.org/10.1016/j.addr.2016.02.002 Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments
https://doi.org/10.1093/annonc/mdy460 Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response—final results from GeparSixto
https://doi.org/10.1055/s-0031-1273201 S3-Leitlinie „Magenkarzinom” -
https://doi.org/10.7326/m19-2125 Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines
https://doi.org/10.1038/modpathol.2016.109 Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group
https://doi.org/10.1038/s41568-023-00576-4 Advances in PET imaging of cancer
https://doi.org/10.1182/blood-2014-04-531871 Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition
https://doi.org/10.1158/2159-8290.cd-17-0273 The Expanding World of N-MYC–Driven Tumors
https://doi.org/10.1111/nyas.12726 Angiopoietin‐2: a multifaceted cytokine that functions in both angiogenesis and inflammation
https://doi.org/10.1055/s-0043-121106 S3-Leitlinie – Kolorektales Karzinom
https://doi.org/10.3390/ijms19092577 Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer
https://doi.org/10.4049/jimmunol.1400330 DAP12-Based Activating Chimeric Antigen Receptor for NK Cell Tumor Immunotherapy
https://doi.org/10.1111/ddg.12113_suppl Malignant Melanoma S3‐Guideline “Diagnosis, Therapy and Follow‐up of Melanoma”
https://doi.org/10.1002/anie.201707875 The Cysteinome of Protein Kinases as a Target in Drug Development
https://doi.org/10.1038/s41571-021-00538-5 International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer
https://doi.org/10.1093/annonc/mdw197 PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab
https://doi.org/10.1055/s-0033-1356220 S3-Leitlinie zum exokrinen Pankreaskarzinom
https://doi.org/10.1093/jnci/djw149 Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy
https://doi.org/10.1186/s12916-018-1163-y Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial
https://doi.org/10.1158/1078-0432.ccr-15-2338 Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer
https://doi.org/10.7150/thno.15253 High-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers
https://doi.org/10.1038/s41467-020-16134-7 The landscape of chromothripsis across adult cancer types
https://doi.org/10.1002/14651858.cd006389.pub2 Interventions to facilitate return to work in adults with adjustment disorders
https://doi.org/10.1038/s41375-020-0806-0 Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
https://doi.org/10.1210/jc.2016-3829 Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas
https://doi.org/10.1136/jitc-2021-004475 The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL
https://doi.org/10.1016/j.breast.2015.07.017 Strategies for developing Ki67 as a useful biomarker in breast cancer
https://doi.org/10.1002/ijc.30828 Precision oncology based on omics data: The NCT Heidelberg experience
https://doi.org/10.1038/s41594-018-0035-7 Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63
https://doi.org/10.1038/s41418-023-01178-1 Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis
https://doi.org/10.1158/1078-0432.ccr-17-3416 Clinical and Pathological Characteristics of KEAP1 - and NFE2L2 -Mutated Non–Small Cell Lung Carcinoma (NSCLC)
https://doi.org/10.1038/s41523-020-0154-2 Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group
https://doi.org/10.1016/j.pec.2016.06.028 Unmet information needs and limited health literacy in newly diagnosed breast cancer patients over the course of cancer treatment
https://doi.org/10.1007/s00401-020-02226-7 Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology
https://doi.org/10.1016/j.annonc.2020.08.2335 NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents
https://doi.org/10.1186/s13014-020-01524-4 Medical physics challenges in clinical MR-guided radiotherapy
https://doi.org/10.7150/thno.7324 Positron Emission Tomography (PET) Imaging of Prostate Cancer with a Gastrin Releasing Peptide Receptor Antagonist - from Mice to Men
https://doi.org/10.1055/s-0033-1355476 Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms
https://doi.org/10.1038/s42256-021-00303-4 Morphological and molecular breast cancer profiling through explainable machine learning
https://doi.org/10.1158/2159-8290.cd-13-0349 Evolution of DNA Methylation Is Linked to Genetic Aberrations in Chronic Lymphocytic Leukemia
https://doi.org/10.1007/s00259-020-05040-1 PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
https://doi.org/10.1038/s41598-017-02608-0 Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma
https://doi.org/10.1002/ana.26172 COVID ‐19 Vaccine‐Associated Cerebral Venous Thrombosis in Germany
https://doi.org/10.1161/circimaging.120.010628 Relationship Between Cardiac Fibroblast Activation Protein Activity by Positron Emission Tomography and Cardiovascular Disease
https://doi.org/10.1038/s41467-022-30050-y The genomic and transcriptional landscape of primary central nervous system lymphoma
https://doi.org/10.1007/s00520-004-0727-x Patient satisfaction and quality of life in cancer outpatients: results of the PASQOC* study
https://doi.org/10.1016/j.ijrobp.2016.10.022 Clinical Implementation of Dual-energy CT for Proton Treatment Planning on Pseudo-monoenergetic CT scans
https://doi.org/10.1186/s12913-015-0707-5 The health literate health care organization 10 item questionnaire (HLHO-10): development and validation
https://doi.org/10.1016/j.cell.2018.11.024 UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors
https://doi.org/10.2967/jnumed.120.242057 Semiautomatically Quantified Tumor Volume Using 68Ga-PSMA-11 PET as a Biomarker for Survival in Patients with Advanced Prostate Cancer
https://doi.org/10.1038/oncsis.2014.51 Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo
https://doi.org/10.1016/j.cell.2023.10.001 Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells
https://doi.org/10.1016/j.trecan.2024.11.009 KRAS inhibitors: resistance drivers and combinatorial strategies
https://doi.org/10.1200/jco.2013.52.3480 Combined Molecular and Clinical Prognostic Index for Relapse and Survival in Cytogenetically Normal Acute Myeloid Leukemia
https://doi.org/10.1007/s11060-020-03640-3 Response to trametinib treatment in progressive pediatric low-grade glioma patients
https://doi.org/10.1093/neuonc/now231 Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas
https://doi.org/10.1093/neuonc/noy118 DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment
https://doi.org/10.1002/cjp2.25 Classical pathology and mutational load of breast cancer – integration of two worlds
https://doi.org/10.1021/acschembio.5b01063 Chemical Proteomics Reveals Ferrochelatase as a Common Off-target of Kinase Inhibitors
https://doi.org/10.1186/s12888-022-03735-3 Prevalence and determinants of anxiety and depression in long-term breast cancer survivors
https://doi.org/10.18632/oncotarget.5417 Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma
https://doi.org/10.1186/s12885-017-3824-1 Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society
https://doi.org/10.1016/j.ijrobp.2015.04.031 Identification of Patient Benefit From Proton Therapy for Advanced Head and Neck Cancer Patients Based on Individual and Subgroup Normal Tissue Complication Probability Analysis
https://doi.org/10.1093/annonc/mdw623 The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast
https://doi.org/10.3389/fonc.2019.01376 The Extracellular, Cellular, and Nuclear Stiffness, a Trinity in the Cancer Resistome—A Review
https://doi.org/10.1259/bjr.20190601 Paediatric proton therapy
https://doi.org/10.1016/j.celrep.2020.107764 Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers
https://doi.org/10.1111/ddg.14048 S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma – short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality‐of‐care indicators
https://doi.org/10.1038/leu.2015.328 Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma
https://doi.org/10.1186/s13012-015-0369-z Reporting standards for guideline-based performance measures
https://doi.org/10.1038/s41467-019-10853-2 Molecular tuning of farnesoid X receptor partial agonism
https://doi.org/10.1038/s41467-021-23855-w Comprehensive micro-scaled proteome and phosphoproteome characterization of archived retrospective cancer repositories
https://doi.org/10.1038/s41467-021-26870-z Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions
https://doi.org/10.1002/anie.202002727 Vancomycin Resistance Is Overcome by Conjugation of Polycationic Peptides
https://doi.org/10.1038/s41379-018-0109-4 An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer
https://doi.org/10.1055/a-0646-4522 Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer
https://doi.org/10.1007/s00401-019-02038-4 Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1
https://doi.org/10.1002/ijc.32496 Targeting ferroptosis in rhabdomyosarcoma cells
https://doi.org/10.1038/s41388-020-1259-7 Loss of the nuclear Wnt pathway effector TCF7L2 promotes migration and invasion of human colorectal cancer cells
https://doi.org/10.1177/0969141321993866 Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: A systematic review for the European Commission Initiative on Breast Cancer
https://doi.org/10.1186/s40168-021-01067-0 Pre-digest of unprotected DNA by Benzonase improves the representation of living skin bacteria and efficiently depletes host DNA
https://doi.org/10.1002/ijc.31992 The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of FANCM pathogenic variants
https://doi.org/10.1016/j.semcancer.2021.02.011 Artificial intelligence and pathology: From principles to practice and future applications in histomorphology and molecular profiling
https://doi.org/10.1016/j.ejca.2021.06.033 Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status
https://doi.org/10.1016/j.omtm.2022.03.018 Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells